These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23677190)

  • 41. Predictors of subjective cognitive complaint in postacute older adult stroke patients.
    Lamb F; Anderson J; Saling M; Dewey H
    Arch Phys Med Rehabil; 2013 Sep; 94(9):1747-52. PubMed ID: 23529143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Information processing efficiency in patients with multiple sclerosis.
    Archibald CJ; Fisk JD
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):686-701. PubMed ID: 11094403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.
    Holmén C; Piehl F; Hillert J; Fogdell-Hahn A; Lundkvist M; Karlberg E; Nilsson P; Dahle C; Feltelius N; Svenningsson A; Lycke J; Olsson T
    Mult Scler; 2011 Jun; 17(6):708-19. PubMed ID: 21228027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.
    Negreiros MA; Mattos P; Landeira-Fernandez J; Paes RA; Alvarenga RP
    Brain Inj; 2008 May; 22(5):419-26. PubMed ID: 18415722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study.
    Sundgren M; Piehl F; Wahlin Å; Brismar T
    Mult Scler Relat Disord; 2016 Nov; 10():36-43. PubMed ID: 27919496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis.
    Bonnet MC; Deloire MS; Salort E; Dousset V; Petry KG; Brochet B;
    J Neurol Sci; 2006 Dec; 251(1-2):23-8. PubMed ID: 17097108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New natural history of interferon-beta-treated relapsing multiple sclerosis.
    Trojano M; Pellegrini F; Fuiani A; Paolicelli D; Zipoli V; Zimatore GB; Di Monte E; Portaccio E; Lepore V; Livrea P; Amato MP
    Ann Neurol; 2007 Apr; 61(4):300-6. PubMed ID: 17444502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatigue and processing speed are related in multiple sclerosis.
    Andreasen AK; Spliid PE; Andersen H; Jakobsen J
    Eur J Neurol; 2010 Feb; 17(2):212-8. PubMed ID: 19796282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
    Vanotti S; Benedict RH; Acion L; Cáceres F;
    Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Executive function and memory in patients with relapsing-remitting multiple sclerosis.
    Cerezo García M; Martín Plasencia P; Aladro Benito Y; Balseiro Gómez JJ; Rueda Marcos A
    Psicothema; 2009 Aug; 21(3):416-20. PubMed ID: 19622322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].
    Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A
    Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
    Weisbrot D; Charvet L; Serafin D; Milazzo M; Preston T; Cleary R; Moadel T; Seibert M; Belman A; Krupp L
    Mult Scler; 2014 Apr; 20(5):588-93. PubMed ID: 24072721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
    Llufriu S; Blanco Y; Martinez-Heras E; Casanova-Molla J; Gabilondo I; Sepulveda M; Falcon C; Berenguer J; Bargallo N; Villoslada P; Graus F; Valls-Sole J; Saiz A
    PLoS One; 2012; 7(5):e37167. PubMed ID: 22606347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].
    Leclercq E; Cabaret M; Guilbert A; Jougleux C; Vermersch P; Moroni C
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Sep; 12(3):331-8. PubMed ID: 25245320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormalities of motor imagery and relationship with depressive symptoms in mildly disabling relapsing-remitting multiple sclerosis.
    Tabrizi YM; Mazhari S; Nazari MA; Zangiabadi N; Sheibani V
    J Neurol Phys Ther; 2014 Apr; 38(2):111-8. PubMed ID: 24531344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive impairment among different clinical courses of multiple sclerosis.
    Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
    Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depression and cognitive impairment in disability-free early multiple sclerosis.
    Haase CG; Tinnefeld M; Lienemann M; Ganz RE; Faustmann PM
    Behav Neurol; 2003; 14(1-2):39-45. PubMed ID: 12719637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.